Who is sponsoring NCT07328659?

NCT07328659 is sponsored by Yasser Gamil Elnagar.

What drugs are being tested in NCT07328659?

Interventions in NCT07328659: Peumatic lithotripsy in mini-pcnl.

What condition does NCT07328659 study?

NCT07328659 studies Kidney Stone, Calculi, Renal.

Is NCT07328659 still recruiting?

NCT07328659 is currently completed. Last updated 15 April 2026.

Last reviewed 2026-04-15 · How we verify

NCT07328659

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Our Stone Fixation Technique to Improve Efficiency and Results of Peumatic Lithotripsy in Suction Mini-PCNL.

Completed NA Last updated 15 April 2026

What this trial tests

NA trial testing Peumatic lithotripsy in mini-pcnl in Kidney Stone in 45 participants. Completed in 1 April 2026.

Timeline

15 January 2024

Primary endpoint
15 September 2025

1 April 2026

Quick facts

Lead sponsor	Yasser Gamil Elnagar
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	45
Start date	15 January 2024
Primary completion	15 September 2025
Estimated completion	1 April 2026
Sites	1 location across Egypt

Drugs / interventions tested

Peumatic lithotripsy in mini-pcnl

Conditions studied

Kidney Stone — all drugs for Kidney Stone →
Calculi, Renal — all drugs for Calculi, Renal →

Sponsor

Yasser Gamil Elnagar

Who can join

Adults 3 to 85, any sex, with Kidney Stone or Calculi, Renal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective study to assist safty and efficieny of our technique of using peumatic lithotripsy with suction mini-pcnl.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Kidney Stone

Currently open trials in the same condition.

NCT06944223 — Oxalate and Citrate in Humans - Response to Citrate · NA · recruiting
NCT07071948 — A Single-Center Clinical Study on the Efficacy and Safety of VISOR · NA · recruiting
NCT06576661 — Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Be · NA · recruiting
NCT06210009 — Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease · NA · recruiting
NCT07238803 — Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07328659 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yasser Gamil Elnagar
Last refreshed: 15 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07328659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing